Nutanix (NASDAQ: NTNX) reported second quarter 2021 earnings results today.
Total revenue remained flat at $346.4 million compared to the same period a year ago.
GAAP net loss was $287.3 million, or $1.42 per share, compared to $217.5 million, or $1.13 per share, last year. Adjusted net loss was $0.37 per share.
Annual contract value billings were up 14% year-over-year to $159.2 million.
For the third quarter of 2021, ACV billings are expected to be $150-155 million.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
